Frank E Thomas Orchard Therapeutics PLC (ORTX) insider trading activity

Frank E Thomas is of Orchard Therapeutics plc. Currently has a direct ownership of 0 shares of ORTX, which is worth approximately $0. The most recent transaction as insider was on Jan 24, 2024, when has been sold 92,081 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

FRANK E THOMAS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 24 2024	SELL Sale (or disposition) back to the issuer	-	92,081 Reduced 100.0%	0 Ordinary Shares
Mar 10 2023	BUY Exercise of conversion of derivative security	$9,200 $0.46 p/Share	20,000 Added 17.84%	92,081 Ordinary Shares
Feb 09 2023	BUY Exercise of conversion of derivative security	$9,200 $0.46 p/Share	20,000 Added 21.72%	72,081 Ordinary Shares
Apr 01 2022	BUY Open market or private purchase	$7,500 $0.75 p/Share	10,000 Added 16.11%	52,081 Ordinary Shares
Jan 29 2021	BUY Exercise of conversion of derivative security	$24,400 $2.44 p/Share	10,000 Added 19.2%	42,081 Ordinary Shares
Jan 11 2021	SELL Payment of exercise price or tax liability	$24,904 $6.72 p/Share	3,706 Reduced 10.36%	32,081 Ordinary Shares
Jan 08 2021	BUY Grant, award, or other acquisition	-	10,667 Added 22.96%	35,787 Ordinary Shares

Also insider at

LRMR

Larimar Therapeutics, Inc. Healthcare

Director

SPRO

Spero Therapeutics, Inc. Healthcare

FET

Frank E Thomas

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORTX shares.

Notify only if

Value

Insider Trading

Get notified when an Orchard Therapeutics PLC insider buys or sells ORTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Orchard Therapeutics plc

Track Activities on ORTX

Account